Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review

Systematic review / meta-analysis OA: closed CC0 ⤵ 11 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

Bilateral salpingo-oophorectomy eliminates ovarian cancer risk but increases risks of heart disease, cancer mortality, and dementia, particularly in younger women without estrogen therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-09 · read from full text ⓘ

This commentary critiques a systematic review on salpingo-oophorectomy during benign hysterectomy, arguing that its recommendations are misleading because they underestimate the impact of increased mortality and accelerated biological aging associated with bilateral oophorectomy. The authors highlight evidence showing that removing ovaries before menopause in women without high-risk genetic variants leads to higher overall mortality and multimorbidity, thereby rendering the procedure ethically questionable. They conclude that bilateral oophorectomy should not be offered as an option to premenopausal women absent specific genetic indications, suggesting that ovarian conservation remains the preferred approach. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: To compare the long-term risks associated with salpingo-oophorectomy with ovarian conservation at the time of benign hysterectomy. DATA SOURCES: MEDLINE, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials were searched from inception to January 30, 2015. We included prospective and retrospective comparative studies of women with benign hysterectomy who had either bilateral salpingo-oophorectomy (BSO) or conservation of one or both ovaries. METHODS OF STUDY SELECTION: Reviewers double-screened 5,568 citations and extracted eligible studies into customized forms. Twenty-six comparative studies met inclusion criteria. Studies were assessed for results, quality, and strength of evidence. TABULATION, INTEGRATION, AND RESULTS: Studies were extracted for participant, intervention, comparator, and outcomes data. When compared with hysterectomy with BSO, prevalence of reoperation and ovarian cancer was higher in women with ovarian conservation (ovarian cancer risk of 0.14-0.7% compared with 0.02-0.04% among those with BSO). Hysterectomy with BSO was associated with a lower incidence of breast and total cancer, but no difference in the incidence of cancer mortality was found when compared with ovarian conservation. All-cause mortality was higher in women younger than age 45 years at the time of BSO who were not treated with estrogen replacement therapy (hazard ratio [HR] 1.41, 95% confidence interval [CI] 1.04-1.92). Coronary heart disease (HR 1.26, 95% CI 1.04-1.54) and cardiovascular death were higher among women with BSO (HR 1.84, 95% CI 1.27-2.68), especially women younger than 45 years who were not treated with estrogen. Finally, there was an increase in the prevalence of dementia and Parkinson disease among women with BSO compared with conservation, especially in women younger than age 50 years. Clinical practice guidelines were devised based on these results. CONCLUSION: Bilateral salpingo-oophorectomy offers the advantage of effectively eliminating the risk of ovarian cancer and reoperation but can be detrimental to other aspects of health, especially among women younger than age 45 years.
Full text 4,152 characters · extracted from oa-html · click to expand
This systematic review of the literature on the controversial topic of salpingo-oophorectomy at the time of benign hysterectomy involved an extensive effort by a large group of experts; however, we are concerned about the overall philosophy of the review, and especially about the conclusions.1 Table 3 includes four recommendations in favor of bilateral salpingo-oophorectomy (BSO) and four against BSO, depending on the outcome of interest. Unfortunately, these recommendations are misleading because mortality has a greater effect on the decision for or against BSO than the risk of reoperation, the avoidance of a rare cancer (ovarian) or of pelvic floor disorders, and the reduction of pain and endometriosis. In Table 2, the authors list three studies considered of good quality for all-cause mortality. Two of the studies clearly showed an increased mortality after BSO.2,3 The third study failed to show an increased mortality possibly because there was a long interval between the oophorectomy and the recruitment into the study (some women may have died before recruitment), the follow-up was short (7.6 years on average), the outcomes present at the time of recruitment were excluded (even though they may have developed after the oophorectomy), and the statistical power was inadequate, thus the study provided lower quality evidence.4 In addition to increasing the risk of overall mortality, it has been recently shown that BSO may accelerate the aging process in all cells, tissues, organs, and systems of the body leading to increased morbidity. Evidence of accelerated aging comes from both biological markers (epigenetic clock) and from clinical measures (accelerated accumulation of multimorbidity).5,6 In conclusion, an elective intervention that causes increased overall mortality and accelerated aging in the entire body is simply not an ethical option. The clinical recommendation should be simple and clear: In the absence of a documented high-risk genetic variant predisposing to ovarian cancer (eg, BRCA mutations), bilateral oophorectomy before the age of 50 years (or before menopause) is never to be considered and should not be offered as an option to women.5,6 The possible alternative strategy of salpingectomy with ovarian conservation remains to be tested scientifically. Footnotes Financial Disclosure The authors did not report any potential conflicts of interest. References - 1.Evans E, Matteson K, Orejuela F, et al. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review. Obstet Gynecol. 2016;128:476–485. doi: 10.1097/AOG.0000000000001592. [DOI] [PMC free article] [PubMed] [Google Scholar] - 2.Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ., 3rd Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006 Oct;7(10):821–828. doi: 10.1016/S1470-2045(06)70869-5. [DOI] [PubMed] [Google Scholar] - 3.Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol. 2009;113(5):1027–1037. doi: 10.1097/AOG.0b013e3181a11c64. [DOI] [PMC free article] [PubMed] [Google Scholar] - 4.Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med. 2011 Apr 25;171(8):760–768. doi: 10.1001/archinternmed.2011.121. 2011. [DOI] [PubMed] [Google Scholar] - 5.Levine ME, Lu AT, Chen BH, Hernandez DG, Singleton AB, Ferrucci L, et al. Menopause accelerates biological aging. Proc Natl Acad Sci U S A. 2016 Jul 25; doi: 10.1073/pnas.1604558113. Jul 25. [DOI] [PMC free article] [PubMed] [Google Scholar] - 6.Rocca WA, Gazzuola-Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, et al. Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study. Mayo Clin Proc. 2016 Sep 28; doi: 10.1016/j.mayocp.2016.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Hysterectomy Ovarian Neoplasms Ovariectomy Salpingectomy Age Factors Female Humans Hysterectomy Organ Sparing Treatments Organ Sparing Treatments Outcome and Process Assessment, Health Care Ovarian Neoplasms Ovariectomy Patient Selection Risk Assessment Salpingectomy

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (67)

Cited by (12)

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
openalex
last seen: 2026-05-13T18:33:16.088889+00:00
pubmed
last seen: 2026-10-08T21:18:17.876363+00:00
unpaywall
last seen: 2026-11-06T06:34:47.334260+00:00
License: CC0 · commercial use OK